DURHAM, N.C., and BEIJING, Jan. 3, 2024 /PRNewswire/ Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company
Item 2.02 Results of Operations and Financial Condition.
To the extent applicable to this Item, the disclosure set forth in Item 8.01 is
incorporated by reference herein.
Item 5.02 Departure of. | January 4, 2023
Charlottesville, VA – HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has received a milestone payment under its October 2020 research collaboration and service agreement with Takeda.
/PRNewswire/ OpenBench, Inc., a pioneer in success-driven hit discovery partnerships, has agreed to assign ownership of two promising chemical series to.
/PRNewswire/ OpenBench, Inc., an emerging leader in AI-enabled small molecule discovery, entered into an agreement with HemoShear Therapeutics, Inc., a.